Our study showed similar findings that MYD88 was the most frequently mutated gene identified in the ctDNA of patients, followed by CD79B, and both mutations occurred in patients with DLBCL, but not in patients with HL or MZL. This evidence concerns the gene CD79B and diffuse large B-cell lymphoma.